Gubbi, Sriram
Hannah-Shmouni, Fady
Stratakis, Constantine A.
Koch, Christian A.
Article History
First Online: 13 December 2018
Compliance with ethical standards
:
: Prof. Koch declares no direct conflict with this article. He has served on the Advisory Board of Novartis on the topic acromegaly and has participated in educational conferences on the topics neuroendocrine tumors and acromegaly sponsored by Novartis and Ipsen. The other authors Drs. Sriram Gubbi, Fady Hannah-Shmouni, and Constantine A. Stratakis declare that they have no conflicts of interest.